Canadian Registry of Electronic Device Outcomes: remote monitoring outcomes in the Abbott battery performance alert—a multicentre cohort
| Autor: | François Philippon, Sharath Kumar, Andrew D. Krahn, Derek V. Exner, Pablo B. Nery, Vidal Essebag, Laurence D. Sterns, Benoit Coutu, Jason Davis, Bernard Thibault, Ratika Parkash, Roopinder K. Sandhu, George A. Wells, Matthew T. Bennett, Iqwal Mangat, Raymond Yee |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Canada
medicine.medical_specialty business.industry medicine.medical_treatment Cardiac resynchronization therapy Implantable cardioverter-defibrillator Defibrillators Implantable Implantable defibrillators Cardiac Resynchronization Therapy Primary outcome Physiology (medical) Emergency medicine Cohort medicine Humans In patient Registries Electronics Cardiology and Cardiovascular Medicine business |
| Zdroj: | EP Europace. 23:1319-1323 |
| ISSN: | 1532-2092 1099-5129 |
| Popis: | Aims Cardiac implantable electronic devices with device advisories have the potential of device malfunction. Remote monitoring (RM) of devices has been suggested to allow the identification of abnormal device performance and permit early intervention. We sought to describe the outcomes of patients with and without RM in devices subject to the Abbott Premature Battery Depletion (PBD) advisory with data from a Canadian registry. Methods and results Patients with an Abbott device subject to the PBD advisory from nine implantable cardioverter defibrillator (ICD) implanting centres in Canada were included in the registry. The use of RM was identified from baseline and follow-up data in the registry. The primary outcome was detection of PBD and all-cause mortality. A total of 2666 patients were identified with a device subject to the advisory. In all, 1687 patients (63.2%) had RM at baseline. There were 487 deaths during follow-up. At a mean follow-up of 5.7 ± 0.7 years, mortality was higher in those without a remote monitor compared with RM at baseline (24.7% vs. 14.5%; P Conclusion The use of RM in patients with ICD and cardiac resynchronization therapy under advisory improved detection of PBD, time to device replacement, and was associated with a reduction in all-cause mortality. The factors influencing the association with mortality are unknown and deserve further study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|